Gastrointestinal Diseases

NASCAR driver helps raise awareness through Racing for a Cause

10 Feb 2012

In 2010, NASCAR Nationwide Series driver Jeremy Clements met young go-kart racer Ricky Springer. They've proven quite a team since.

Ventrus Biosciences - What's Ahead?

9 Feb 2012

It's been a little over a year since Ventrus Biosciences Inc. (VTUS), which is developing drugs that address an unmet need in gastrointestinal diseases, went public at $6 per share. This specialty pharmaceutical company, whose stock now trades around $9, has two catalysts in the coming months.

Synergy Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference

9 Feb 2012

Synergy Pharmaceuticals, Inc. , a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that its President and CEO, Gary S. Jacob, Ph.D, will present at the 14th Annual BIO CEO & Investor Conference.